Skip to main content
Cybin Inc. logo

Cybin Inc. — Investor Relations & Filings

Ticker · HELP NEO Manufacturing
Open in API
Filings indexed 441 across all filing types
Latest filing 2025-07-01 Earnings Release
Country CA Canada
Listing NEO HELP

About Cybin Inc.

http://www.cybin.com

Cybin Inc. is a clinical-stage biopharmaceutical company specializing in breakthrough neuropsychiatry, committed to developing next-generation therapeutics to revolutionize mental healthcare. The company utilizes proprietary drug discovery platforms to innovate Novel Serotonergic Agonists (NSAs)—synthetic molecules designed to activate serotonin pathways and promote neuroplasticity—paired with precision drug delivery systems. A core technological differentiator is the use of deuteration technology to create treatments with consistent delivery and commercial scalability. Cybin maintains a robust intellectual property portfolio, including over 100 granted patents and 250 pending applications, supporting its active drug programs, such as CYB004, currently in Phase 2 clinical trials for the treatment of Generalized Anxiety Disorder. The mission is to provide treatments designed to foster durable improvements in mental health.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Earnings Release Classification · 1% confidence The document is a press release titled “Cybin Reports Fiscal Year 2025 Financial Results and Recent Business Highlights.” It provides key highlights of financial performance (cash position, net loss, operating expenses, cash flows) for the fiscal year ended March 31, 2025, along with business and clinical pipeline updates. It does not include the full audited annual report detail (MD&A, notes, full financial statements) but instead presents summarized results and operational highlights. This matches the definition of an Earnings Release (ER). FY 2025
2025-07-01 English
52-109F1 - Certification of annual filings - CEO (E).pdf
Management Reports Classification · 1% confidence The document is titled “Management’s Discussion and Analysis” (MD&A) for the nine months ended April 30, 2025. It provides management’s explanation of operational results, financial condition, business overview, acquisitions, and forward-looking statements in accordance with Canadian securities regulations. This matches the definition of a Management Report (MDA).
2025-07-01 English
52-109F1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a Form 52-109F1 “Certification of Annual Filings” signed by the CFO under Canadian securities regulation (National Instrument 52-109). It is not the annual report itself, nor an announcement that an annual report is published, nor an auditor’s report, but a management certification filing required by securities rules. It does not fit into specialized categories like audit report (AR) or an earnings release (ER), so it falls into the general regulatory filings category.
2025-07-01 English
Annual information form - English.pdf
Annual Report Classification · 1% confidence The document is explicitly titled 'ANNUAL INFORMATION FORM' (AIF) for Cybin Inc. for the year ended March 31, 2025. In Canadian securities regulation, an Annual Information Form is a disclosure document that provides material information about a company and its business, which is filed alongside or as part of the annual reporting package. Given the provided filing categories, '10-K' is the closest equivalent for a comprehensive annual disclosure document, as it covers company activity, business structure, risk factors, and governance, serving the same functional purpose as a 10-K in the US market. FY 2025
2025-07-01 English
News release - English.pdf
Capital/Financing Update Classification · 1% confidence The document is a corporate press release announcing a new financing transaction – the private placement of up to US$500 million in convertible debentures, discussion of transaction terms, use of proceeds, placement agent, and regulatory exemptions. This is a classic fundraising/capital structure update rather than an earnings release, regulatory notice, or full financial report. It best fits the “Capital/Financing Update” category (Code: CAP).
2025-07-01 English
Annual MD&A - English.pdf
Management Reports Classification · 1% confidence The document is titled “Management’s Discussion and Analysis of Financial Condition and Operating Performance” for the year ended March 31, 2025 and contains management’s narrative on business overview, forward-looking statements, risk factors, corporate structure, and financial condition. This is the MD&A section, which is a standalone management report providing detailed explanations of financial results, business trends, and outlook. Therefore, it matches the definition of Management Reports (MDA).
2025-07-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.